Search

Itranstad

Itranstad

itraconazole

Manufacturer:

Stellapharm

Distributor:

HK Medical Supplies
/
Health Express
Concise Prescribing Info
Contents
Itraconazole
Indications/Uses
Short-term treatment: Vulvovag candidiasis, pityriasis versicolor, dermatophytosis, fungal keratitis & oral candidiasis. Long-term treatment: Systemic aspergillosis & candidiasis, cryptococcosis (including cryptococcal meningitis), histoplasmosis, sporotrichosis, paracoccidioidomycosis, blastomycosis & other rarely occurring systemic or tropical mycosis.
Click to view Itranstad detailed prescribing information
Dosage/Direction for Use
Vulvovag candidiasis 2 cap once daily for 3 days or 2 cap bd for 1 day. Pityriasis versicolor/dermatophytosis 2 cap once daily for 7 days. Dermatophytosis in highly keratinized regions eg, plantar & palmar 2 cap bd for 7 days. Oral candidiasis 1 cap once daily for 15 days. Fungal keratitis 2 cap once daily for 21 days. Onychomycosis Pulse treatment 2-3 pulse treatments (about 7 days each): 4 cap daily (2 cap morning, 2 cap evening). Pulse treatment are separated by a 3-wk drug-free interval. Continuous treatment 2 cap daily for 3 mth. Aspergillosis 2 cap once daily for 2-5 mth. Increase dose to 2 cap bd in invasive or disseminated disease. Candidiasis 1-2 cap daily for 3 wk-7 mth. Increase dose to 2 cap bd in invasive or disseminated disease. Non-meningeal cryptococcosis 2 cap once daily for 2-12 mth. Cryptococcal meningitis 2 cap bd for 2-12 mth. Maintenance: 2 cap once daily. Histoplasmosis 2 cap once daily to bd for 8 mth. Sporotrichosis 1 cap once daily for 3 mth. Paracoccidioidomycosis 1 cap once daily for 6 mth. Chromoblastomycosis 1-2 cap once daily for 6 mth. Blastomycosis 1 cap once daily to 2 cap bd for 6 mth.
Click to view Itranstad detailed prescribing information
Overdosage
View Itranstad overdosage for action to be taken in the event of an overdose.
Administration
Should be taken with food: Take immediately after a full meal.
Contraindications
Hypersensitivity.
Click to view Itranstad detailed prescribing information
Special Precautions
Decreased oral bioavailability in cirrhotic patients & patients w/ renal insufficiency. Monitor itraconazole plasma conc & adapt the dose when necessary. Should not be administered in patients w/ history of hepatic diseases or hepatotoxicity caused by other drugs. Monitor liver function in patients receiving continuous treatment (>1 mth). Not recommended during lactation. Not to be used in childn unless potential benefit outweighs potential risks.
Click to view Itranstad detailed prescribing information
Adverse Reactions
Nausea, abdominal pain, headache, dyspepsia.
Drug Interactions
Concomitant use w/ terfenadine, astemizole, cisapride, dofetilide, pimozide, or quinidine is contraindicated. Reduced oral bioavailability w/ enzyme-inducing drugs eg, rifampicin & phenytoin. Reports of drug interactions w/ cyclosporine A. Reports of vomiting & nausea w/ digoxin.
Click to view Itranstad detailed prescribing information
Storage
View Itranstad storage conditions for details to ensure optimal shelf-life.
Description
View Itranstad description for details of the chemical structure and excipients (inactive components).
MIMS Class
Antifungals
ATC Classification
J02AC02 - itraconazole ; Belongs to the class of triazole and tetrazole derivatives. Used in the systemic treatment of mycotic infections.
Presentation/Packing
Form
Itranstad cap 100 mg
Packing/Price
6's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in